eBay Inc vs Summit Therapeutics Inc — how do they compare? eBay Inc trades at $102.5 (market cap $47.17B), while Summit Therapeutics Inc trades at $15.1 (market cap $12.06B). The key difference: eBay Inc is far larger — about 3.9× Summit Therapeutics Inc's market cap, and eBay Inc pays a 1.17% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| EBAY | SMMT | |
|---|---|---|
Market Cap | $47.17B | $12.06B |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $26.98 |
52-Week Low | $79.41 | $12.55 |
Enterprise Value | $51.00B | $11.39B |
Dividend Yield | 1.17% | — |
Signals from Pluang's Aura AI — not financial advice
EBAY trades at $102.23, down 5.09% amid reports GameStop may abandon its $56 billion takeover bid in favor of a partnership. The stock shows bearish technical signals with support near $104, while fundamentals remain solid with Q2 2026 earnings beating estimates and an 18.57% net income margin. Revenue growth is projected to reach $12.0 billion in 2026, though cash flow turned negative in 2025.
The outlook is mixed: strong execution and a potential partnership or buyout offer present upside, but withdrawal of the bid and insider selling pose near-term risks. Analyst consensus is a $119.31 price target with a buy rating, but investors face volatility from deal uncertainty and competitive pressures in e-commerce.
Summit Therapeutics (SMMT) trades at $15.23, up 2.42% today, with a bullish technical signal and strong analyst consensus. The stock shows mixed earnings performance but benefits from positive news on ivonescimab's regulatory progress and clinical expansions. Despite negative profitability metrics, investor sentiment is buoyed by a high price target of $38.00 and recent partnership announcements in cancer drug development.
Outlook hinges on FDA approval for ivonescimab by November 2026, offering significant upside if successful. Risks include cash burn, ongoing losses, and fiduciary investigations. The stock presents a high-risk, high-reward opportunity for speculative investors betting on clinical successes.
Trailing returns across standard periods
Latest headlines on both assets
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →